Gujarat Kidney

  • Market Cap: N/A
  • Industry: Hospital
  • ISIN: INE0V0W01025
  • NSEID: GKSL
  • BSEID: 544666
INR
105.50
1.45 (1.39%)
BSENSE

Feb 03

BSE+NSE Vol: 5.46 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

5.46 lacs (-27.34%) Volume

Shareholding (Dec 2025)

FII

10.47%

Held by 9 FIIs

DII

1.67%

Held by 1 DIIs

Promoter

71.45%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Hospital

stock-summary
Market cap

INR 833 Cr ()

stock-summary
P/E

572.00

stock-summary
Industry P/E

56

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

448.92

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Icon
Company does not have enough history
Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

10-Jan-2026 | Source : BSE

Please find enclosed Certificate under Regulation 74(5) under SEBI (Depositories and Participants) Regulation 2018 for the quarter ended 31st December2025.

Board Meeting Outcome for Outcome Of Board Meeting Hold On 6Th January 2026.

06-Jan-2026 | Source : BSE

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) read with Schedule III to the Listing Regulations this is to inform you that the Board of Directors of the Company at its Meeting held today i.e. on Tuesday 6th January 2025 (which commenced at 5:00 p.m. and concluded at 6:00 .p.m.) inter alia has approved the following:- 1) APPROVAL FOR AQUIRE REMAINING 49% SHARES OF M/S. HARMONY MEDICARE PRIVATE LIMITED AND TO MAKE THEM AS WHOLLY OWNED SUBSIDIARY COMPANY. 2) ACCORDING TO ACQUISITION AGREEMENT AND THE ACQUISITION AGREEMENT-II AND OBJECT OF THE ISSUE OF INITIAL PUBLIC OFFERING THE BOARD OF DIRECTORS APPROVED TO MAKE PART PAYMENT OF RS. 1240 LAKHS AS PURCHASE CONSIDERATION FOR THE ALREADY ACQUIRED ASHWINI MEDICAL CENTRE

Board Meeting Outcome for Intimation Of Outcome Of Board Meeting Held On 2Nd January 2026

02-Jan-2026 | Source : BSE

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) read with Schedule III to the Listing Regulations this is to inform you that the Board of Directors of the Company at its Meeting held today i.e. on Friday 2nd January 2025 (which commenced at 10:00 a.m. and concluded at 11:00 a.m.) inter alia has approved the following:- 1) APPROVAL FOR ACQUISITION OF 100% EQUITY STAKE IN PAREKHS HOSPITAL PRIVATE LIMITED AND FOR EXECUTION OF SHARE PURCHASE AGREEMENT WITH THE PROMOTER GROUP OF PAREKHS HOSPITAL PRIVATE LIMITED : The Board of Directors has approved the purchase / acquisition of 100% Equity Stake in Parekhs Hospital Private Limited to make that Company as a wholly owned subsidiary of the Company..

Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
1.25
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
12.15%
ROCE (avg)
49.23%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
572
Industry P/E
56
Price to Book Value
454.96
EV to EBIT
651.10
EV to EBITDA
533.29
EV to Capital Employed
320.56
EV to Sales
167.19
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
49.23%
ROE (Latest)
79.51%
Technicals key factors
Indicator
Weekly
Monthly
Icon
No records
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 9 FIIs (10.47%)

Promoter with highest holding

Pragnesh Yashwantsinh Bharpoda (38.16%)

Highest Public shareholder

Craft Emerging Market Fund Pcc-citadel Capital Fund (3.89%)

Individual Investors Holdings

11.57%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Gujarat Kidney"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Gujarat Kidney"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Gujarat Kidney"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "alert": "No Annual Results declared by Gujarat Kidney"
  }
]
stock-summaryCompany CV
About stock-summary
stock-summary
Company Coordinates stock-summary
Company Details
stock-summary
Tel:
stock-summary
stock-summary
Registrar Details